Antenatal Corticosteroids and Clinical Outcomes of Preterm Singleton Neonates with Intrauterine Growth Restriction

키워드

참고문헌 (32)

1. Committee on Obstetric Practice, "Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation", Obstet Gynecol, 130, pp.e102~e109 (2017)
2. Liggins GC, "A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants", Pediatrics, 50, pp.515~525 (1972)
3. Roberts D, "Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth", Cochrane Database Syst Rev, 3, pp.CD004454~ (2017)
4. "Effect of corticosteroids for fetal maturation on perinatal outcomes", NIH Consens Statement, 12, pp.1~24 (1994)
5. Magann EF, "Use of antenatal corticosteroids in special circumstances: a comprehensive review", Acta Obstet Gynecol Scand, 96, pp.395~409 (2017)
6. Ishikawa H, "The effects of antenatal corticosteroids on short- and long-term outcomes in small-for-gestational-age infants", Int J Med Sci, 12, pp.295~300 (2015)
7. Melamed N, "Antenatal corticosteroids and outcomes of small-for-gestational- age neonates", Obstet Gynecol, 128, pp.1001~1008 (2016)
8. 김우정, "Antenatal corticosteroids and outcomes of preterm small-for-gestational-age neonates in a single medical center", Obstetrics & Gynecology Science, 61(1), pp.7~13 (2018), 대한산부인과학회[DOI]
9. Torrance HL, "Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and", or maternal hypertension, 2007, pp.20, 613~621
10. Bernstein IM, "Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network", Am J Obstet Gynecol, 182(1 Pt 1), pp.198~206 (2000)
11. van Stralen G, "No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study", Early Hum Dev, 85, pp.253~257 (2009)
12. Schaap AH, "Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants", Obstet Gynecol, 97, pp.954~960 (2001)
13. Simchen MJ, "The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction", Am J Obstet Gynecol, 190, pp.296~304 (2004)
14. Sharma D, "Intrauterine growth restriction: antenatal and postnatal aspects", Clin Med Insights Pediatr, 10, pp.67~83 (2016)
15. Bell MJ, "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging", Ann Surg, 187, pp.1~7 (1978)
16. Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm", J Pediatr, 92, pp.529~534 (1978)
17. Olsen IE, "New intrauterine growth curves based on United States data", Pediatrics, 125, pp.e214~e224 (2010)
18. Sweet DG, "European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2013 update", Neonatology, 103, pp.353~368 (2013)
19. Economides DL, "Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses", Fetal Ther, 3, pp.158~164 (1988)
20. Torrance HL, "Is antenatal steroid treatment effective in preterm IUGR fetuses", Acta Obstet Gynecol Scand, 88, pp.1068~1073 (2009)
21. Miller SL, "The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus", Endocrinology, 148, pp.1288~1295 (2007)
22. McTernan CL, "Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms", J Clin Endocrinol Metab, 86, pp.4979~4983 (2001)
23. Ozdemir H, "A placebocontrolled comparison of effects of repetitive doses of betamethasone and dexamethasone on lung maturation and lung, liver, and body weights of mouse pups", Pediatr Res, 53, pp.98~103 (2003)
24. Bertram C, "The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11betahydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero", Endocrinology, 142, pp.2841~2853 (2001)
25. Morrison JL, "Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost", Reprod Sci, 16, pp.527~538 (2009)
26. Riskin-Mashiah S, "Antenatal corticosteroid treatment in singleton, small-for-gestational-age infants born at 24-31 weeks' gestation: a population-based study", BJOG, 123, pp.1779~1786 (2016)
27. Ting JY, "Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age", Am J Obstet Gynecol, 218(2S), pp.S818~S828 (2018)
28. McGillick EV, "Risk of respiratory distress syndrome and efficacy of glucocorticoids: are they the same in the normally grown and growth-restricted infant?", Reprod Sci, 23, pp.1459~1472 (2016)
29. Elimian A, "Antenatal corticosteroids: are incomplete courses beneficial", Obstet Gynecol, 102, pp.352~355 (2003)
30. Miller SL, "Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus", Am J Obstet Gynecol, 201, pp.e1~e8 (2009)
31. Lai MY, "Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn", Pediatr Neonatol, 59, pp.15~23 (2018)
32. Mitsiakos G, "Are antenatal steroids beneficial to severely growth restricted fetuses", J Matern Fetal Neonatal Med, 26, pp.1496~1499 (2013)

관련 논문AI추천